RxDoctor Payments Data

Diane Johnson

Family Medicine · Midlothian, VANPI 1306839550

Payments from drug & device makers

$5,249in general payments, 2019–2025

Across 297 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$855
  • AstraZeneca$756
  • GSK$434
  • Novo Nordisk$400
  • Amgen$357
  • Lilly USA, LLC$331
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$5,249100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,249 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$199,776
Medicare patients
405
Services billed
4,653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$133,662
JardianceEmpagliflozin57$69,675
EliquisApixaban54$49,773
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$36,114
MounjaroTirzepatide28$31,817
FarxigaDapagliflozin Propanediol32$27,185
MyrbetriqMirabegron25$20,072
TrulicityDulaglutide13$15,753
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$10,293
Diclofenac Sodium86$8,512
Oxycodone Hcl155$5,973
Lantus SolostarInsulin Glargine,hum.Rec.Anlog61$5,243
Tresiba Flextouch U-100Insulin Degludec14$4,901
Testosterone19$4,772
Breo ElliptaFluticasone/Vilanterol12$4,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$400$133,66278 claims
Boehringer IngelheimJardiance, Stiolto Respimat$199$79,96872 claims
PfizerEliquis, Paxlovid$330$51,20273 claims
Lilly USA, LLCMounjaro, Trulicity$331$47,57041 claims
GSKTrelegy Ellipta, Breo Ellipta$434$40,87249 claims
AstraZenecaFarxiga, Symbicort$756$31,66552 claims
Astellas Pharma US IncMyrbetriq$20$20,07225 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$52$3,048336 claims
AbbVieArmour Thyroid$855$1,68715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →